Decentralized Community agencies: Agency for the evaluationof medicinal products

OBJECTIVE: to amend Regulation (EEC) No 2309/93 establishing the Agency for the Evaluation of Medicinal Products in order to modify the regulatory framework governing the management of the Agency's budget. CONTENT: the proposed changes relate to: - power of discharge: as this body is partly self-sufficient as far as its resources are concerned, a joint power of discharge is proposed. Discharge will be given by the board of directors to the director of the Agency, at the recommendation of the European Parliament; - own resources: as the Agency has resources other than those from its annual budgetary allocation, it is proposed that surplus revenue be paid back into the general budget of the European Union once a reserve has been set up to meet any future expenditure. The sums allocated to this reserve must be agreed by the Commission, after consulting the European Parliament; - financial control: financial control of the Agency will be carried out by the Commission's Financial Controller.�